CoChat

Strategy for “Detoxification” of a Cancer-Derived Histone Mutant Based on Mapping Its Interaction with the Methyltransferase PRC2

Open access
Brown, Zachary Z., Müller, Manuel M., Jain, Siddhant U., Allis, C. David, Lewis, Peter W., Muir, Tom W. · 2014 · Journal of the American Chemical Society

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

The histone methyltransferase PRC2 plays a central role in genomic stability and cellular development. Consequently, its misregulation has been implicated in several cancers. Recent work has shown that a histone H3 mutant, where the PRC2 substrate residue Lys27 is replaced by methionine, is also associated with cancer phenotypes and functions as an inhibitor of PRC2. Here we investigate the mechanism of this PRC2 inhibition through kinetic studies and photo-cross-linking. Efficient inhibition is dependent on (1) hydrophobic lysine isosteres blocking the active site, (2) proximal residues, and (3) the H3 tail forming extensive contacts with the EZH2 subunit of PRC2. We further show that naturally occurring post-translational modifications of the same H3 tail, both proximal and distal to K27M, can greatly diminish the inhibition of PRC2. These results suggest that this potent gain of function mutation may be “detoxified” by modulating alternate chromatin modification pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/ja5060934

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 2

  1. Wu G.; Broniscer A.; McEachron T. A.; Lu C.; Paugh B. S.; Becksfort J.; Qu C.; Ding L.; Huether R.; Parker M.; et al. St. Jude Children’s Research Hospital-Washington University Pediatric Cancer Genome Project. Nat. Genet. 2012, 44, 251.22286216
  2. Copeland R. A. Reversible Inhibitors. In Enzymes; John Wiley & Sons, Inc.: Hoboken, NJ, 2002; pp 266– 304.

Cited by

See all 123

Metadata

Authors
Brown, Z. Z., Müller, M. M., Jain, S. U., Allis, C. D., Lewis, P. W., & Muir, T. W.
Affiliations
  • Princeton University (US)
  • Princeton University , , , ,
  • University of Wisconsin–Madison (US)
  • Rockefeller University (US)
Corresponding author
Muir, Tom W.
Venue
Journal of the American Chemical Society
Published
2014-09-02
Volume
136
Issue
39
Pages
13498-13501
ISSN
  • 0002-7863 (ISSN-L)
  • 1520-5126
OpenAlex
W2314376783
Cited by
111
References
19
Citations by year
2026: 5 · 2025: 5 · 2024: 8 · 2023: 8 · 2022: 12 · 2021: 9 · 2020: 9 · 2019: 18 · 2018: 11 · 2017: 13 · 2016: 7 · 2015: 5 · 2014: 1
FWCI
3.55
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Chemical Society (publishedVersion, other-oa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Funders
  • National Institute of General Medical Sciences (R01 GM107047, R37-GM086868)
  • STARR foundation (I6-A614)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
Keywords
H3K27M mutation, polycomb repressive complex 2, EZH2, histone methyltransferase inhibition, cancer, protein-protein interaction, photocrosslinking, enzyme kinetics, chromatin modification, gain-of-function mutations
MeSH terms
Enzyme Inhibitors, HeLa Cells, Histones, Humans, Kinetics, Models, Molecular, Mutation, Neoplasms, Polycomb Repressive Complex 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.